Resource listing

In this analysis by Dr Martin Turner, Director of Policy and External Affairs, BIA, discover how the 2025 Budget could supercharge UK life sciences scale-ups with major investment incentives - while also highlighting potential risks from rising business rates.

Following the FDA approval of Immunocore's treatment of metastatic uveal melanoma (mUM), KIMMTRAK, guest author Sir John Bell shares what this could mean for the UK life sciences.

Ahead of BioBeat24, Iraida Soria-Espinosa, Senior Innovation & Business Manager at UK DRI, and Miranda Weston-Smith, Founder of BioBeat, caught up with keynote speaker Zoe Kourtzi, Professor of Computational Cognitive Neuroscience at the University of Cambridge.

In this blog, Emma Lawrence, Head of Data Tech Policy and Public Affairs at BIA, explains why BIA is publishing a health data access industry checklist to support data access.

In this blog, Maddie Cass, Senior Policy and Public Affairs Executive at BIA, explores a major milestone for agricultural innovation in England: the implementation of a clear, science-based regulatory pathway for precision-bred plants.

A highlight of the life sciences calendar and celebrating the achievements of the life science sector, the sold out 2021 Bionow Awards showcased the very best of this world class field.

Dr Mark Kotter, CEO and Founder of bit.bio, stem cell biologist and complex spine neurosurgeon, speaks about the company and the importance of SynBio as part of the UK Life Sciences Vision.